Companies: 10,838     total market cap: $147.757 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Summit Therapeutics
SMMT
#1676
Rank
$12.89 B
Marketcap
๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom
Country
$16.62
Share price
-4.87%
Change (1 day)
-35.71%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

P/S ratio for Summit Therapeutics (SMMT)

P/S ratio as of May 2026 (TTM): N/A

According to Summit Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 20.1. At the end of 2026 the company had a P/S ratio of N/A.

P/S ratio history for Summit Therapeutics from 2017 to 2019

PS ratio at the end of each year

Year P/S ratio Change
2026N/A
2025N/A
2024N/A
2023N/A-100%
2022> 1000735.25%
2021145-67.68%
20204501130.37%
201936.510727.26%
20180.3375-98.4%
201721.1-87.5%
2016168

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Sarepta Therapeutics
SRPT
0.8174N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
3.02N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com